Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
04 2022
Historique:
revised: 26 01 2022
received: 19 11 2021
accepted: 31 01 2022
pubmed: 17 3 2022
medline: 13 4 2022
entrez: 16 3 2022
Statut: ppublish

Résumé

To quantitatively evaluate upper limb ataxia using a novel pen-like sensor device in patients with spinocerebellar ataxia (SCA) and to assess its validity, reliability, and sensitivity to disease progression. We designed a cross-sectional and longitudinal study of patients with SCA and healthy controls. Upper limb ataxia was evaluated using a device that measures the three-dimensional position every 10 msec. Participants were instructed to move a pen-like part of the device iteratively between two buttons. We evaluated the time, length, velocity, and variation coefficient of the stroke, and calculated the distortion index using the mean squared error. The following scales were also evaluated: Scale for the Assessment and Rating of Ataxia (SARA), the International Cooperative Ataxia Rating Scale (ICARS), and the nine-hole pegboard test. Subjects were followed 12 months after the baseline evaluation. A total of 42 patients with SCA and 33 healthy controls were enrolled and evaluated. For all ataxia indices measured using the device there were significant differences between healthy controls and patients with SCA. Among the ataxia indices, the distortion index showed the strongest correlation with the SARA and ICARS upper limb score (Pearson's r = 0.647 and 0.722, respectively). Test-retest reliability was high for most of the ataxia indices. In the longitudinal analysis, the distortion index showed high standardized response mean and adjusted effect size, regardless of disease severity. Our study demonstrated that the distortion index is a reliable functional marker that is sensitive to longitudinal change in patients with SCA.

Identifiants

pubmed: 35293156
doi: 10.1002/acn3.51528
pmc: PMC8994984
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-539

Informations de copyright

© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Brain Nerve. 2017 Aug;69(8):879-890
pubmed: 28819072
Lancet Neurol. 2015 Nov;14(11):1101-8
pubmed: 26377379
Neurology. 2006 Jun 13;66(11):1717-20
pubmed: 16769946
Mov Disord. 2011 Sep;26(11):2081-7
pubmed: 21626567
Int J Integr Care. 2002;2:e15
pubmed: 16896390
Brain. 1998 Apr;121 ( Pt 4):561-79
pubmed: 9577385
Mov Disord. 2007 Oct 15;22(13):1976-9
pubmed: 17876849
Mov Disord. 2006 May;21(5):699-704
pubmed: 16450347
Lancet Neurol. 2004 May;3(5):291-304
pubmed: 15099544
J Neurol. 2014 Jul;261(7):1381-6
pubmed: 24781836
Clin Biomech (Bristol, Avon). 2013 Apr;28(4):386-94
pubmed: 23538127
Singapore Med J. 2005 Apr;46(4):153-9; quiz 160
pubmed: 15800720
Neurology. 2008 Sep 23;71(13):982-9
pubmed: 18685131
PLoS One. 2011;6(8):e22293
pubmed: 21829612
Cerebellum. 2019 Aug;18(4):721-730
pubmed: 30993540
Neurology. 2008 Aug 12;71(7):486-92
pubmed: 18695159
J Neurol Sci. 1997 Feb 12;145(2):205-11
pubmed: 9094050
Orphanet J Rare Dis. 2014 Jul 23;9:118
pubmed: 25053188
Am J Health Syst Pharm. 2008 Dec 1;65(23):2276-84
pubmed: 19020196
Int J Rehabil Res. 2012 Mar;35(1):1-12
pubmed: 22315141
Brain. 1999 May;122 ( Pt 5):871-82
pubmed: 10355672
Orphanet J Rare Dis. 2013 Nov 13;8:177
pubmed: 24225362
Cerebellum. 2012 Mar;11(1):155-66
pubmed: 21701895
Cerebellum. 2017 Apr;16(2):518-524
pubmed: 27830516
Neurology. 2010 Feb 23;74(8):678-84
pubmed: 20177122
Front Neurol. 2020 Mar 11;11:179
pubmed: 32218767
Mov Disord. 2011 Feb 15;26(3):534-8
pubmed: 21287600
Neurology. 2005 Apr 12;64(7):1209-14
pubmed: 15824348
Mov Disord. 2009 Jul 15;24(9):1387-90
pubmed: 19441132
Neurology. 2012 Feb 21;78(8):545-50
pubmed: 22323747
Cell Transplant. 2017 Mar 13;26(3):503-512
pubmed: 28195034
Lancet Neurol. 2015 Oct;14(10):985-91
pubmed: 26321318
Neurology. 2011 Sep 13;77(11):1035-41
pubmed: 21832228
J Neurol. 2019 Feb;266(2):533-544
pubmed: 30284037
Am J Occup Ther. 1985 Jun;39(6):386-91
pubmed: 3160243
Brain. 2008 May;131(Pt 5):1352-61
pubmed: 18378516
Eur J Neurol. 2009 Feb;16(2):232-9
pubmed: 19146643
Brain. 2018 Jan 1;141(1):248-270
pubmed: 29206893

Auteurs

Yoshiyuki Kishimoto (Y)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Atsushi Hashizume (A)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuta Imai (Y)

Department of Basic Medicinal Sciences, Nagoya University Graduate School of Pharmaceutical Sciences, Nagoya, Japan.

Masahiro Nakatochi (M)

Public Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shinichiro Yamada (S)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Daisuke Ito (D)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Ryota Torii (R)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshitaka Nagano (Y)

Department of Electronic Robot Engineering, Aichi University of Technology, Gamagori, Japan.

Hideo Fujimoto (H)

Department of Computer Science and Engineering, Nagoya Institute of Technology Graduate School of Engineering, Nagoya, Japan.

Masahisa Katsuno (M)

Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH